Suchergebnisse - "Koch, Alisa E"

PubPharm (301)

1

Mammalian Glycosylation Patterns Protect Citrullinated Chemokine MCP-1/CCL2 from Partial Degradation

enthalten in: International journal of molecular sciences | 2023

von Korchynskyi, O. | Yoshida, K. | Korchynska, N. | +8

2

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States

enthalten in: Advances in therapy | 2022

von Choong, C. | Belger, M. | Koch, A. | +5

3

Retraction : CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway

enthalten in: Cancer research | 2022

von Wang, J. | Lu, Y. | Wang, J. | +3

RetractionOf: Cancer Res. 2008 Dec 15;68(24):10367-76. - PMID 19074906

4

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States

enthalten in: Advances in therapy | 2022

von Choong, C. | Belger, M. | Koch, A. | +5

5

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States

enthalten in: Advances in therapy | 2022

von Choong, C. | Belger, M. | Koch, A. | +5

6

Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States

enthalten in: Advances in therapy | 2022

von Choong, C. | Belger, M. | Koch, A. | +5

7

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

enthalten in: Annals of the rheumatic diseases | 2022

von Dörner, T. | Tanaka, Y. | Dow, E. | +7

8

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2020

von Thudium, C. | Bay-Jensen, A. | Cahya, S. | +5

9

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

enthalten in: Arthritis Research & Therapy | 2020

von Thudium, C. | Bay-Jensen, A. | Cahya, S. | +5

10

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

enthalten in: Arthritis Research & Therapy | 2020

von Thudium, C. | Bay-Jensen, A. | Cahya, S. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]